close

Enter

Log in using OpenID

Cancer Metabolism Based Therapeutics Market

embed
This has revealed that heterogeneity is developed at cellular level leading to proliferation of cancerous cells due to increased metabolism rate
Cancer Metabolism Based Therapeutics
Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Cancer Metabolism Based Therapeutics Market – Overview
Rafael pharmaceuticals, introduced a breakthrough drug, CPI-613 in 2017, which is an anti-cancer
compound - Altered Energy Metabolic Directed (AEMD) drug specifically designed to target the
mitochondrial tricarboxylic acid (TCA) cycle in cancer metabolism. CPI-613 is being evaluated in clinical
trial phase II. The Food and Drug Administration (FDA) designated CPI-613 as an orphan drug for the
treatment of pancreatic cancer, acute myeloid leukemia (AML), and Myelodysplastic syndromes (MDS).
Rafael intends to apply CPI-613, as an orphan drug designation for MYC amplified lymphoma/Burkitt
lymphoma and T-cell lymphoma in near future. Therefore, offering orphan drug to the cancer patients
would help to gain more value and share for cancer metabolism based therapeutics market.
Celgene Corporation and Agios Pharmaceutical announced that the Food and Drug Administration (FDA)
approved New Drug Application (NDA) for enasidenib – oral form, in August 2017. The FDA granted the
NDA, as a priority review for cancer metabolism drug. Enasidenib is a first-in-class drug, which is
expected to target relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase 2
(IDH2) mutation.
REPORT DESCRIPTION
Cancer Metabolism Based Therapeutics Market – Taxonomy
By Drug –
●
CPI-613
●
Enasideni
By Indication –
●
Acute Myeloid Leukemia (AML)
●
Myelodysplastic Syndromes (MDS)
●
Metastatic Renal Cell Carcinoma
●
Melanoma
●
Others
Get PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/961
REPORT DESCRIPTION
Cancer Metabolism Based Therapeutics Market – Key Players
•
•
•
•
•
Calithera Biosciences, Inc,
Celgene Corporation,
Agios Pharmaceutical,
Rafael pharmaceuticals, 3-V Biosciences,
and AstraZeneca.
Read More @
https://www.coherentmarketinsights.com/ongoing-insight/cancer-metabolism-based-therapeutics-market-961
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
Author
priya saraf
priya saraf66   documents Email
Document
Category
Health and Medicine
Views
2
File Size
446 KB
Tags
cancer metabolism based therapeutics market, therapeutics
1/--pages
Report inappropriate content